Patent details

Basic Information

Publication number:

EP2272503

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP100080647

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Oral formulations of cladribine

French Title of Invention:

Formulation orale de cladribine

German Title of Invention:

Orale Zubereitungen enthaltend Cladribin

SPC Number:

Dates

Filing date:

26/03/2004

Grant date:

20/03/2013

EP Publication Date:

20/03/2013

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

12/01/2011

EP B1 Publication Date:

20/03/2013

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

26/03/2013

Expiration date:

26/03/2024

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

26/03/2004

 

 

Name:

Ares Trading S.A.

Address:

Zone Industrielle de l'Ouriettaz, 1170 Aubonne, Switzerland (CH)

Inventor

1

Name:

Bodor Nicholas, S.

Address:

United States (US)

2

Name:

Dandiker Yogesh

Address:

United Kingdom (GB)

Priority

1

Priority Number:

458922 P

Priority Date:

28/03/2003

Priority Country:

United States (US)

2

Priority Number:

484756 P

Priority Date:

02/07/2003

Priority Country:

United States (US)

3

Priority Number:

541247 P

Priority Date:

04/02/2004

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 9/20;

Filing date	Document type	Number of pages